07/11/2022 - General information
At the same time, the head of the Haematological Cytology section of the Pathology Service of the Hospital del Mar and researcher at the Hospital del Mar Medical Research Institute, is secretary of the board of directors of the Spanish Group for Haematological Cytology and also holds the same position in the Spanish Group of Myelodysplastic Syndromes.
04/11/2022 - Institutional news
This list takes into account the most cited scientists in various disciplines, divided into 22 fields of knowledge. Stanford University, in the United States, has just published the update of the list that represents the 2% of the most cited scientists in various disciplines. The World's Top 2% Scientist, which includes more than 200,000 of the more than eight million science professionals considered to be active in the world, includes 22 professionals from the Hospital del Mar Medical Research Institute and the Hospital del Mar in its two rankings, the one that takes into account their entire career and the one that focuses on the last few years.
03/11/2022 - General information
On 3 November, the 36 projects selected by the La Marató Foundation Board of Trustees, at the proposal of the Scientific Advisory Committee, were made public. Of these, four are led by researchers from Hospital del Mar and the IMIM, and the centres are participating in two others. La Marató de TV3 i Catalunya Ràdio has selected six projects that involve Hospital del Mar and the Hospital del Mar Medical Research Institute. These will receive funding from the La Marató 2021 call for grants, which is dedicated to mental health. In total, 36 proposals from 81 research teams have been selected to receive a share of the more than 12.1 million euros raised in the latest edition of the programme. The IMIM-Hospital del Mar is one of the centres with the most projects selected from the 150 proposals submitted.
03/11/2022 - Press release
A study led by researchers at the Hospital del Mar Medical Research Institute links psychological trauma in childhood with an increased risk of developing some kind of mental disorder years later. This is the first study to analyse the relationship between psychological trauma and various mental pathologies at a transdiagnostic level. It examines fourteen already published reviews or meta-analyses, involving more than 90,000 participants. The study is published in the European Archives of Psychiatry and Clinical Neuroscience and demonstrates the need to study the history of patients suffering from a mental disorder.
02/11/2022 - General information
The researcher of the Neuroscience Research Program at the Hospital del Mar Medical Research Institute talks in this book with Montserrat Pedreira, PhD in Education and Early Childhood Education teacher, about how we communicate, what makes us curious and how we explore the world. Beatriz Fagundo, PhD in Neuroscience and researcher at the Neuroscience Research Program at IMIM-Hospital del Mar, is one of the authors of Diàlegs entre educació i neurociència, a book that explores the common ground between Neuroscience and Education through a dialogue between the researcher and Montserrat Pedreira, PhD in Education and Early Childhood and Primary Education teacher. The book is published by Eumo Editorial.
Més informació "Diàlegs entre educació i neurociència, the new book of Beatriz Fagundo"
28/10/2022 - General information
This is a study cohort comprising 200,000 people, which will be used to study and improve the health of the Spanish population. Dr. Jordi Alonso, head of the Health Services Research Group at the IMIM-Hospital del Mar, is a member of the project's executive committee, which has just completed its first year of work. The Hospital del Mar Medical Research Institute is one of the 21 Spanish institutions that, together with the National Statistics Institute (INE), form part of the IMPaCT Cohort project. This initiative is aimed at creating a cohort of 200,000 people over the age of fifteen and using them to study and improve the health of the population. The project has been running for a year, and a meeting was held at the end of September, in Alcalá de Henares, to analyse its progress.
27/10/2022 - General information
On the occasion of the Pharmacist's Day, last October 18, the Barcelona College of Pharmacists awarded the Prize for the best community project in the CARGENCORS Study: Cardiovascular Genetic risk score for Risk Stratification of patients positive for the SARS-CoV-2 (COVID-19) virus, led by researchers and physicians from the Hospital del Mar Medical Research Institute (IMIM), the Institute of Biomedical Research of Girona. Josep Trueta (IDIBGI), the University Institute for Primary Care Research (IDIAP Jordi Gol) and the University of Vic-Central University of Catalonia.
Més informació "The College of Pharmacists of Barcelona awards the CARGENCORS study"
27/10/2022 - Covid-19
A study by the Hospital del Mar Medical Research Institute and Pompeu Fabra University has found that not all HIV patients respond adequately to the SARS-CoV-2 vaccine. The work has been published in the journal Frontiers in Immunology. Up to 20% of people with HIV being treated with antiretroviral drugs do not regain normal levels of immune cells in their blood. These people, with a depressed immune system, are considered to be at risk of SARS-CoV-2 infection and were prioritised in the COVID-19 vaccination strategy, just as other at-risk groups were. However, until now it was not known how they responded to immunisation with RNA-based vaccines, such as those from Pfizer and BioNTech.
26/10/2022 - Press release
People with low levels of this compound who suffer this pathology have almost a 40% greater risk of dying or being admitted to hospital than those with higher levels. This is according to a study carried out jointly by Hospital Germans Trias i Pujol and the Hospital del Mar Medical Research Institute (IMIM-Hospital del Mar). The research team analysed blood samples from 905 patients with heart failure, who were monitored for three years. The results of the study have been published in the Journal of the American College of Cardiology.
24/10/2022 - General information
The principal investigator of the Research Group on Cell-type mechanisms in normal and pathological behavior at the Hospital del Mar Medical Research Institute received this award at the IACM congress held in Switzerland. Every two years, the International Association for Cannabinoid Medicines (IACM) awards different categories of prizes to researchers working in the field of cannabinoids. This year, the selection committee of this international association has decided to award the Young Investigator Award for research in the field of cannabinoids to Dr. Arnau Busquets, principal investigator of the Research Group on Cell-type mechanisms in normal and pathological behavior at the Hospital del Mar Medical Research Institute (IMIM).
Més informació "IACM Young Investigator Award for Dr. Arnau Busquets"
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
